BIOCRAFT AMILORIDE/HYDROCHLOROTHIAZIDE LAUNCH BOOSTS SALES AND EARNINGS "SIGNIFICANTLY"; CEFADROXIL ADDS TO NEARLY 50% SALES HIKE IN SECOND QUARTER